Loading...
News2019-02-08T15:19:04-05:00

NEWS FROM REVEN

09/08/2017|

Reven received approval for our Family Two 1st Divisional Patent.

08/18/2017|

Reven submits divisional patents in Canada and Mexico.

07/24/2017|

Reven receives approval in Canada for our Family Two Patent.

07/10/2017|

Reven selected an Australian Contract Manufacturing Organization (CMO) to supply drug product for Phase I [...]